Area deprivation and cancer-specific mortality in non-muscle-invasive bladder cancer: a statewide analysis.
Socioeconomic disparities and bladder cancer stage at diagnosis: a statewide cohort analysis.
Weight Gain Was Associated With Worsening Glycemia and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes Independent of Diabetes Medication in the GRADE Randomized Controlled Trial
Unveiling racial disparities in prostate cancer using an integrative genomic and transcriptomic analysis.
Racial Disparities in Future Development of Lethal Prostate Cancer Based on Midlife Baseline Prostate-Specific Antigen.
Association of race with incidence, characteristics, and mortality from incidental prostate cancer: Analysis of two North American contemporary cohorts.
Editorial Comment: A Qualitative Analysis of Telemedicine Use Among Urban and Rural Patients With Urologic Malignancies
Editorial Comment: Combining Prostate MRI and Microultrasound to Omit Systematic Biopsy
Impact of Upstaging From cT2a-b to pT3a on Overall Survival Among Patients With Renal Cell Carcinoma.
Editorial Comment: Systematic Review and Meta-Analysis on the Timing and Severity of Prostate Biopsy Infections
Editorial Comment: Effect of Cranberry Juice Consumption on the Urobiome in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Stur, E, Peng, F, Teng, PN, Bayraktar, E, Hu, M, Corvigno, S, Brown, DJ, Lee, S, Moore, KN, Bateman, NW, Darcy, KM, Maxwell, GL, P. Conrads, T, Sahni, N, Vázquez-García, I, Shah, S, Celestino, J, D. Fleming, N, Navin, N, Wang, L, Sood, AK . The dynamic immune behavior of primary and metastatic ovari
— 2025cited by 0position: selected
Emotional Distress Predicts Reduced Type 2 Diabetes Treatment Adherence in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study)
Differential Effects of Type 2 Diabetes Treatment Regimens on Diabetes Distress and Depressive Symptoms in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
Long-Term Oncological Outcomes in Patients Diagnosed With Nonmetastatic Plasmacytoid Variant of Bladder Cancer: A 20-Year University of Texas MD Anderson Cancer Center Experience.
The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing Literature.
The Impact of Radical Prostatectomy Versus Radiation Therapy on Cancer-Specific Mortality for Nonmetastatic Prostate Cancer: Analysis of an Other-Cause Mortality Matched Cohort.
Race has no impact on prostate cancer-specific mortality, when comparing patients with similar risk of other-cause mortality: An analysis of a population-based cohort.
Prostate Specific Antigen Screening on a Nationwide Level: Featuring the Contribution of Race and Life Expectancy in Decision Making.
Optimizing anti-androgen treatment use among men with pathologic lymph-node positive prostate cancer treated with radical prostatectomy: the importance of postoperative PSA kinetics.
Editorial Comment: Impact of Androgen Deprivation Therapy on Lumbar Spine Bone Health Using Quantitative Computed Tomography in a Propensity-Matched Cohort of Patients With Prostate Cancer
From the Editor September 2024: The Spectrum of Clinical Trial Reports
Moving the Needle: Integrating Available Risk Stratification Tools for Optimizing Diagnosis of Prostate Cancer
Is pT0 a Reliable End Point for Biomarker Discovery for Preoperative Chemotherapy Response in Patients With Bladder Cancer?
Editorial Comment: Management of a Colorenal Fistula After Percutaneous Cryoablation for Renal Cell Carcinoma
Czopik, A, McNamee, EN, Vaughn, V, Huang, X, Bang, IH, Clark, T, Wang, Y, Ruan, W, Nguyen, T, Masterson, JC, Tak, E, Frank, S, Collins, CB, Li, H, Rodriguez-Aguayo, C, Lopez Berestein, G, Gerich, ME, Furuta, GT, Yuan, X, Sood, AK , De Zoeten, EF, Eltzschig, H . HIF-2α-dependent induction of miR-29a
— 2024cited by 0position: selected
Lutgendorf SK, Telles RM, Whitney B, Thaker PH, Slavich GM, Goodheart MJ, Penedo FJ, Noble AE, Cole SW, Sood AK , Corn BW . The biology of hope: Inflammatory and neuroendocrine profiles in ovarian cancer patients. Brain Behav Immun 116:362-369, 2024. e-Pub 2024. PMID: 38081436.
— 2024cited by 0position: selected
Hinchcliff EM, Knisely A, Adjei N, Fellman B, Yuan Y, Patel A, Xu C, Westin SN, Sood AK , Soliman PT, Shafer A, Fleming ND, Gershenson DM, Vikram R, Bathala T, Vining D, Ganeshan DM, Lu KH, Sun CC, Meyer LA, Jazaeri AA . Randomized phase 2 trial of tremelimumab and durvalumab in combination versus s
— 2024cited by 0position: selected
How JA, Legarreta AF, Handley KF, Fellman B, Foster KI, Glassman D, Vuttaradhi VK, Brodsky AL, Lawson B, Frumovtiz M, Westin SN, Ramondetta LM, Gershenson DM, Sood AK , Hillman RT . Serial cytoreductive surgery and survival outcomes in recurrent adult-type ovarian granulosa cell tumors. Am J Obstet
— 2024cited by 0position: selected